chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Knee pain; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old male patient received the unknown dose number of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, after the vaccination, the patient experienced knee pain that was not previously extant. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event knee pain was resolved with sequelae on an unknown date.  No follow-up attempts are possible. No further information is expected.
Bruning and neck pain x 2 days after shot, then back/spine pain, moving over to both hip joints and Pelvic area. Created severe pain requiring use of Ibuprofen for pain, and using a walker to relieve pressure on weight bearing joints.
Nausea, vomiting, diarrhea. Onset 1-2 hrs after vaccine administration.
Initially arm sore and swollen on 2nd day. Had body aches, chills, diarrhea, tiredness day 3-5 with continued arm site swollen and sore.  On 1/5/20, swelling was decreased to about size of nickel and less sore. On 1/6, arm became more sore, noticed increased swelling and now redness to arm site 1/6 evening. 1/7 Arm remains swollen, red, warm to touch. No drainage. Reported to superviser 1/7 am.
Pt. inadvertently administered Pfizer monovalent formulation instead of bivalent at community event.  Pt. informed.
Intense pins needles in right fingertips burning up to elbow; Intense pins needles in right hand and fingers/ intense pins needles in right fingertips burning up to elbow; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 16Apr2021 at 13:30 (at the age of 16-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. It was unknown whether the patient have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On 17Apr2021 at 03:00, the patient experienced intense pins needles in right hand and fingers, lasted 30 minutes subsided with only expected soreness at injection site. On 18Apr2021 at 19:00, the patient experienced intense pins needles in right fingertips burning up to elbow lasting 2 hours and continuing. It was reported that began 30 minutes after doing homework, right-handed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense pins needles in right hand and fingers/ intense pins needles in right fingertips burning up to elbow and soreness at injection site were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Missed the 2-6 month window; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 71-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received 1st dose on an Unknoen date).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Missed the 2-6 month window).  The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 06-MAR-2023 The reporter was curious about the upper limit for the 2nd dose of shingrix. The reporter asked if there a point where the series must be restarted or just do the 2nd dose anytime if they had missed the 2 to 6 month window. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. This case conservatively kept valid for event incomplete course of vaccine ation due to limited information.
12 hours after receiving #2 shot, woke up with chills/body aches  & pain to injection site, shoulder & neck with fatigue & body aches.  The pain worsened to site, shoulder neck.  The evening on Thursday, Lymph Nodes in neck were inflamed.  Friday a doctor visit occured with a diagnosis of Reactive Lymphadenopathy.    Motrin suggested every 8 hours.  Monday 2/1/21-  Neck and shoulder still very tender/sore & lymph enlarged.  Physician would like a follow-up in 2 weeks if not resolved.
I was told that shortly after injection the patient complained of a burning sensation in her arm. The next day the patient's parents made us aware of a splotchy rash that spread from the injection site in the deltoid all the way down to the wrist. The burning sensation was still occurring. I instructed the patient to take antihistamines and ibuprofen and if it worsens or continues to seek further care and let us know.
Chills; Headache; Arm pain; Shoulder pain; Neck pain (left side); Stiff neck (left side); Joint pain knees; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 01Apr2021 at 11:45(at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included heart failure and emphysema. Concomitant medications included dutasteride (AVODART), rosuvastatin calcium (CRESTOR), enalapril maleate, hydrochlorothiazide (ENALAPRIL H), metoprolol succinate (TOPROL XL) and acetylsalicylic acid (ASP); all from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the arm left on 11Mar2021 at 13:15 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 11:45 the patient experienced Chills, Headache, Arm pain, Shoulder pain, Neck pain, Stiff neck all left side and Joint pain knees. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events Chills, Headache, Arm pain, Shoulder pain, Neck pain, Stiff neck and Joint pain knees was unknown.  No follow-up attempts are needed. No further information is expected.
about 2 weeks post shot pt has developed what appears to be a case of shingles. has lesion on forehead and all over body includiong fingers. tiredness as well. treated with valtrex , gabapentin and tac cream 0.1%
4/23 - Achy, could not walk up and down stares.  Pink prickly rash - 4/25 (trunk and extremities) no resp. symptoms. Arthralgia, joint pain , weak, tired. No fever, wrists and hands painful and weak.  Neck felt funny, lymph nodes felt "weird".  Redness in eyes, looked like conjunctivitis (per patient).
Patient received the Moderna Booster and was not 18+, as was signed up for and approved by her parent/guardian. After waiting 15 minutes post administration, patient did not report any signs of difficulty breathing, anaphalayxis, allergic, or other unintended outcome. Patient left with her parent/guardian.
Three months after taking the 2nd dose, I developed a blood clot on my left leg. I was prescribed with Eliquis, a blood thinner. Also, my blood pressure decreased to a very low state. Recently my blood pressure has improved, but I am still dealing with the blood clot.
Scaling and peeling of all 10 fingers and all 10 toes, palms of hand, soles of feet. Severe itching and redness.
Patient received PNEUMOVAX 23 on 12/18/16 at approximately 5pm. (PNEUMNOVAX 23 Merck Lot # Mo13156 exp 10/15/2017) per protocol. At 1am the following morning, the patient had significant swelling, redness, and pain that extended to his elbow, shoulder and under his chin. He was admitted to Medical Center and was discharged 12/22/16. The patient said the swelling and pain had improved considerably but was not completely resolved.
After giving vaccination, upon further review of record, client had received Bivalent Pfizer previously on 09/30/2022.
Aproximately 5 minutes after receipt of 2nd dose, patient began feeling hot, and dizzy. Symptoms progressed to gagging, loss of vision and hearing.  Patient was placed in the modified tredelenburg postion, vital signs obtained and monitored for roughly 40 minutes. Vital signs were initially low, RN assessed patient had not even prior to vaccine adminsitration. Offered water and energy bar, placed bag of ice on back of neck. Patient did not experience and respiratory distress throughout event.  Mother was educated on signs and symptosm to monitor for post vaccine and if any new or worsending symptoms presented to seek care at the emergency room.
Information has been received from a healthcare worker referring to three unspecified patients of unknown age and gender. The three patients' medical history, concurrent conditions and concomitant medications were not provided. On multiple unspecified dates the three unspecified patients were vaccinated with improperly stored doses of VARIVAX (lot #, expiration date, dose, route and site of administration were not reported) for prophylaxis. The vaccines were exposed to 33.8 degrees Fahrenheit for 327 hours. The temperatures were logged with a data logger and there was no previous excursion.  No adverse effect was reported. Additional information has been requested.
Patient reports feeling nerve pain, tingling,  weakness, and shaking in the arm he received the vaccine.  This started the day of the vaccine and continued through today.
Evening of injection-"whole upper arm sore and a little swollen. The next day, Thursday 1/28/16, my arm continued to swell and I had a low grade fever in the afternoon.  When I got up on Friday morning, 1/30/16, I had a low grade fever of 102.8 and my arm was swollen, extremely painful and had a red rash.
Persistent pain in upper left arm, stiffness in neck and shoulder due to pain, pain radiating from nervous system as well (intermittent).
8/9/2021: Patient is a 56 year old female presented with complaints of shortness of breath, fatigue, cough and diarrhea x 1 week. Pt notes being vaccinated fully for covid-19 with Pfizer vaccine since May 2021. In the ED she is found to have a positive covid-19 test, her oxygen saturation 89% on room air, elevated d dimer 1.8, Na 129, SCr 2.89. Chest x-ray showed mildly decreased lung volumes, stable from prior with accentuated vascular markings and mild left basilar atelectasis. She states she gets dizzy when standing and has trouble with her balance. 8/16/2021: Patient still admitted at the time of this report She was given IVF and Dexamethasone in the ED and will be admitted for further evaluation and management.
the patient was so so sick; ended up with full blown flu; Initial information regarding this unsolicited valid non-serious social media via case was received from a consumer (patient) and transmitted to Sanofi on 22-Oct-2020.  This case was linked to cases 2020SA300020, 2020SA300035, 2020SA300034, 2020SA300036, 2020SA300037, 2020SA300038, 2020SA300040, 2020SA300041, 2020SA300042, 2020SA300043, 2020SA300044 and 2020SA300045.  This case involved a patient with unknown demographics, who was so so sick (illness) and ended up with full blown flu (influenza), while the patient received vaccine INFLUENZA VACCINE.  Relevant medical history, past medical treatment, vaccination, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was so sick (illness) and ended up with full blown flu (influenza) unknown latency following the administration of INFLUENZA VACCINE.  Relevant laboratory test was not reported.  Final diagnosis was illness and influenza.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported events.  There would be no information available on batch number for this case.
86 year old female with COPD, HTN, hx hep C, and fibromyalgia with crhonic pain admitted from facility with covid pneumonia. Patient with progression to 16 L O2 needs and was given dose of tocilizumab, as well as decadron and remdesivir. However, on day 4 of admission elected to transition to comfort care. All covid treatment and non comfort drive medications were stopped. She remained stable for 24 hours on 6 L NC and was discharged back to custodial facility with hospice. Using prn roxanol for discomfort.    Subjective: Tearful this am and anxious about transfer home. Breathing stable. Some cough.    Objective: BP 164/78  | Pulse 74  | Temp 97.9 °F (36.6 °C)  | Resp 17  | Ht 5'  | Wt 52.2 kg (115 lb)  | SpO2 90%  | Breastfeeding Yes  | BMI 22.46 kg/m²    Physical Exam at Discharge: Comfort care, full exam deferred Anxious but no acute distress Non labored breathing   Selected Results: Recent Labs No results found for this or any previous visit (from the past 24 hour(s)).    Primary Procedures:  None   Secondary Procedures: None   Reason for Hospital Admission (Admitting Diagnosis):  covid pneumonia
Pt recvd HIB/DTP & 15 minutes p/immun, a rash started @ the HIBTITER inject site, spread to arms, then all over-became urticarial & pt was given Epi & DPH;
pt died next Am in bed but at autopsy had large abscess @ bladder & surgical incision site from urological surgery 10/6/99;
pt recv vax & devel nausea,resp diff,dizziness & numbness;pt was taken to ER for tx;
injection site pain, redness, and swelling traveling to her wrist; injection site pain, redness, and swelling traveling to her wrist; injection site pain, redness, and swelling traveling to her wrist; injection site pain, redness, and swelling traveling to her wrist; injection site pain, redness, and swelling traveling to her wrist; Information has been received from a medical assistant, referring to a 74 years old female patient. The patient had none concomitant therapy, pertinent medical history or drug reactions/allergies. It was also reported on an unknown date, the patient received pneumococcal 13v conj vaccine (CRM197)(PREVNAR 13).  On 28-AUG-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # R034248, expiration date: 07-AUG-2020, 1 dosage form, strength and frequency were unknown) intramuscularly in the left arm for prophylaxis.         On the same day, the patient called to report "injection site pain, redness, and swelling traveling to her wrist". The medical assistant told the patient to "apply ice to her wrist". On 30-AUG-2019 (or 31-AUG-2019), the patient returned to the office and was prescribed unspecified oral steroids. Treatments were given for the events. None lab diagnostics or studies were performed. The patient had sought medical attention. The outcome of the events was unknown. The causality assessment was not provided by the reporter.
given within 10 days of Pfizer COVID Vaccine (second dose received 2/20/2021)-no reaction at time of injection
Pt was administered vaccine. Was sitting in chair for 5 mins then began to clench fists, fold into fett. position bending over and hit L temple gently on conference table. Face red, cold, clamy. Sweating. Passed out for approx 1 1/2 mins regained consciousness. BP 88/48, 48, 16. + 95.3 pl. after 3 minutes again for BP 82/80-school nurse notified. EMS notified-transported via ambulance to hospital where pt stayed for 2 1/2 hrs before being released.
Red rash; Developed delayed cutaneous hypersensitivity Covid arm rash on the arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS ALLERGIC (Developed delayed cutaneous hypersensitivity Covid arm rash on the arm of injection) and RASH ERYTHEMATOUS (Red rash) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031MZ0A) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation and Bladder cancer (Patient was dealing with a catheter and the possibility of more surgery and chemo.). Concurrent medical conditions included Drug allergy (HCTZ). Concomitant products included TOCAINIDE, METOPROLOL SUCCINATE (TOPROL), ATORVASTATIN, RIVAROXABAN (XARELTO), MULTIVITAMIN [VITAMINS NOS], VITAMIN D NOS and FLECAINIDE for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced DERMATITIS ALLERGIC (Developed delayed cutaneous hypersensitivity Covid arm rash on the arm of injection). On an unknown date, the patient experienced RASH ERYTHEMATOUS (Red rash). At the time of the report, DERMATITIS ALLERGIC (Developed delayed cutaneous hypersensitivity Covid arm rash on the arm of injection) and RASH ERYTHEMATOUS (Red rash) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered DERMATITIS ALLERGIC (Developed delayed cutaneous hypersensitivity Covid arm rash on the arm of injection) to be possibly related. No further causality assessment was provided for RASH ERYTHEMATOUS (Red rash).    No concomitant medication information was provided  No treatment medications were reported.  On 03 JUL 2021 patients wife reported that her husband just had surgery for bladder cancer and we are consumed at the moment with recovery, dealing with a catheter and the possibility of more surgery and chemo.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jul-2021: Follow up information received on 03 JUL 2021. Procedural history (Bladder cancer) was updated. On 13-Jul-2021: Live follow up information received on 13 JUL 2021. Patient demographic (height, weight), suspect product details (Anatomical Location), event details (Rash erythematous), event outcome, concomitant medications, causality of the event Dermatitis allergic was possible were updated.
Fever; Muscle aches; Pains; Sensitivity to light; Nausea; Chills; Sweats; Overall lethargy; Irregular heart rate; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration in right arm on 16Mar2021 at 14:30 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took cefalexin (KELFLEX) and amoxicillin; clavulanic acid (AUGMENTIN) and experienced drug allergy on an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021 at 23:45, the patient experienced fever, muscle aches, pains, sensitivity to light, nausea, chills, sweats, overall lethargy, irregular heart rate. The patient did not receive any treatment for the reported events. The clinical outcome of the fever, muscle aches, pains, sensitivity to light, nausea, chills, sweats, overall lethargy, irregular heart rate was recovering.   No follow-up attempts are needed. No further information is expected.
About 5 minutes after receiving the vaccine, the patient fell out of his chair in the waiting room. Vaso-vagal reaction. pt was pale, sweaty and clammy, shaking after he passed out, did not know where he was when he woke up. Was out for approximately 30 seconds. EMS arrived to check vitals which were normal and he was released.
No adverse effects reported.; one patient was administered an irmroperly stored dose of PROQUAD; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions or medical history provided. Concomitant therapies included sterile diluent.  On 08-MAY-2019, the patient was vaccinated subcutaneously with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S002503, expiration date 23-JUL-2020, albumin status rHA (recombinant Human albumin) (dose and route of administration were not reported) for prophylaxis. There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 7 degrees Celsius for 72 hours.  Data logger was involved. There were no previous excursions reported.
Patient has syncopal event at front desk after vaccine administration. Came to quickly and felt better within 10 minutes.
I noticed a lump a week prior to Mammogram (Sept 3rd). Feels itchy, lump on top of breast.
Started out as an anxiety attack triggered by sensitivity to the vaccine.  I then had weakness in my legs and pains in my head, neck, arm.  I could not sleep the first night and felt a little better after 24 hours but then the pains in my right knee and hips slowly started getting worse.
Shot received at 10:15 am 10:45 am palms get hot and itchy. 12:15 pm tongue feels heavy and swollen, , throat is itchy and a shallow, dry cough devlops, lips swell, itchy palms, rapid heartbeat. Gets better after 30 minutes  3:45 pm same reactions occur again. Resolve when I take 4 Benadryl. Next day, feel better but tongue tingly and slight cough with itchy throat, headache, and overall fatigue.
On 5/8/2021 patient started experiencing dyspnea with it worsening and leading to hospitalization on 5/11/2021 for respiratory failure/COPD exacerbation. Patient is currently inpatient on med surg unit currently on Vapotherm at 40% FiO2.
pt recvd Hep B vax 10AUG94 & mid AUG94 devel malar rash, fever, arthralgias & hypertension; late SEP94, dx w/SLE w/nephritis & anemia; tx Pred; 6OCT94 renal biopsy revealed class VI glomerulonephritis; +ANA; pos DSDNA antibody; resp distres